Skip to main content
Equibles
SABS logo

SABS · SAB Biotherapeutics, Inc. · Exempt Offerings

Track SABS — free

Use SABS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SABS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.16 +0.09 (+2.77%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$285.96M
Shares
90.99M
Volume · Oct 28 157.48K Avg daily vol (3M) 528.92K

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2025-08-05 New $175,000,000 $175,000,000
2023-10-16 New $7,500,000 $7,500,000
Showing 1–2 of 2 filings
Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 8 filings 8 filers Visit website Investor relations